METTL3-mediated ANXA2 inhibition confers neuroprotection in ischemic stroke: Evidence from in vivo and in vitro studies.
FASEB J
; 37(7): e22974, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37249328
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Brain Injuries
/
Brain Ischemia
/
Stroke
/
Ischemic Stroke
Limits:
Animals
/
Humans
Language:
En
Year:
2023
Type:
Article